Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |